|
|
|
LifeScienceHistory.com - Check us out on Instagram
Texas Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing TexasLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Evestra Inc.
| | | Phone: | (210) 673-3300 | Fax: | (210) 673-3322 | Year Established: | 2008 | Main Contact: | Ze’ev Shaked, Ph.D., Co-Founder, President & CEO | | Other Contacts: | John Kerr, Chairman Klaus Nickisch, Ph.D., Co-Founder, CSO & Managing Director
| | Company Description | Evestra is a biopharmaceutical research and development company with a therapeutic focus in women’s healthcare. Evestra is conducting research and product development in a number of important women’s healthcare areas, including among others, indications such as endometriosis, fibroids, fertility control (FC), hormone replacement therapy (HRT), and overactive bladder (OAB). Evestra’s product pipeline includes pre-clinical products and clinical stage products. Their lead product candidate is EVE116, a second generation vaginal ring contraceptive, which will be undergoing Phase II clinical studies in Europe in early 2018. They expect to bring the first products to market in 2019 via collaborations with Gedeon Richter and Glenmark. | |
|
|
|
|
|